These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19778551)

  • 1. Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine.
    Struthers AM; Wilkinson JL; Dwoskin LP; Crooks PA; Bevins RA
    Pharmacol Biochem Behav; 2009 Dec; 94(2):319-28. PubMed ID: 19778551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine-induced enhancement of responding for conditioned reinforcement in rats: role of prior nicotine exposure and α4β2 nicotinic receptors.
    Guy EG; Fletcher PJ
    Psychopharmacology (Berl); 2013 Jan; 225(2):429-40. PubMed ID: 22885874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected loss of sensitivity to the nicotinic acetylcholine receptor antagonist activity of mecamylamine and dihydro-β-erythroidine in nicotine-tolerant mice.
    de Moura FB; Wilkerson JL; McMahon LR
    Brain Behav; 2020 Apr; 10(4):e01581. PubMed ID: 32092237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats.
    Liu X; Palmatier MI; Caggiula AR; Donny EC; Sved AF
    Psychopharmacology (Berl); 2007 Nov; 194(4):463-73. PubMed ID: 17616849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
    Cunningham CS; Javors MA; McMahon LR
    J Pharmacol Exp Ther; 2012 Jun; 341(3):840-9. PubMed ID: 22438471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
    Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):426-34. PubMed ID: 16220336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
    Smith AM; Dhawan GK; Zhang Z; Siripurapu KB; Crooks PA; Dwoskin LP
    Biochem Pharmacol; 2009 Oct; 78(7):889-97. PubMed ID: 19631612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.
    Murray JE; Walker AW; Polewan RJ; Bevins RA
    Psychopharmacology (Berl); 2011 Jan; 213(1):131-41. PubMed ID: 20859617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
    Wooters TE; Smith AM; Pivavarchyk M; Siripurapu KB; McIntosh JM; Zhang Z; Crooks PA; Bardo MT; Dwoskin LP
    Br J Pharmacol; 2011 May; 163(2):346-57. PubMed ID: 21232049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.
    Rahman S; Zhang Z; Papke RL; Crooks PA; Dwoskin LP; Bardo MT
    Br J Pharmacol; 2008 Feb; 153(4):792-804. PubMed ID: 18059317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
    Beckmann JS; Meyer AC; Pivavarchyk M; Horton DB; Zheng G; Smith AM; Wooters TE; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
    Neurochem Res; 2015 Oct; 40(10):2121-30. PubMed ID: 26227997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
    Dwoskin LP; Wooters TE; Sumithran SP; Siripurapu KB; Joyce BM; Lockman PR; Manda VK; Ayers JT; Zhang Z; Deaciuc AG; McIntosh JM; Crooks PA; Bardo MT
    J Pharmacol Exp Ther; 2008 Aug; 326(2):563-76. PubMed ID: 18460644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic aspects of the discriminative stimulus effects of arecoline.
    Winger G
    Behav Pharmacol; 2021 Oct; 32(7):581-589. PubMed ID: 34417356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
    Jutkiewicz EM; Brooks EA; Kynaston AD; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):194-202. PubMed ID: 21730011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine enhances responding for conditioned reinforcement via α4β2 nicotinic acetylcholine receptors in the ventral tegmental area, but not the nucleus accumbens or the prefrontal cortex.
    Tabbara RI; Fletcher PJ
    Neuropharmacology; 2019 Apr; 148():68-76. PubMed ID: 30550794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Feb; 111(2):406-13. PubMed ID: 8004384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of nicotine self-administration with nicotinic antagonists in rats.
    Watkins SS; Epping-Jordan MP; Koob GF; Markou A
    Pharmacol Biochem Behav; 1999 Apr; 62(4):743-51. PubMed ID: 10208381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
    Khan IM; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discriminative stimulus effects of i.v. nicotine in rhesus monkeys: Pharmacokinetics and apparent pA
    Moerke MJ; Zhu AZ; Tyndale RF; Javors MA; McMahon LR
    Neuropharmacology; 2017 Apr; 116():9-17. PubMed ID: 27940077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.